Roger G. Stoll PhD - 23 May 2024 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 May 2024, 16:23:56 UTC
Prior SEC filing
21 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Hoffman, Attorney-in-Fact

Key filing fact

Roger G. Stoll PhD filed Form 4 for DELCATH SYSTEMS, INC. (DCTH) on 28 May 2024.

Key facts

  • This page summarizes Roger G. Stoll PhD's Form 4 filing for DELCATH SYSTEMS, INC. (DCTH).
  • 10 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 28 May 2024, 16:23.

Change

  • Previous filing in this sequence was filed on 21 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DCTH transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-142
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
142
Exercise price
$196.70
Footnotes
F1, F2
DCTH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+142
Change %
Price
$0.000000
Shares after
142
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
142
Exercise price
$196.70
Footnotes
F2
DCTH transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-40,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$11.67
Footnotes
F3
DCTH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+40,000
Change %
Price
$0.000000
Shares after
40,000
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$11.67
Footnotes
F3
DCTH transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-9,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,000
Exercise price
$10.16
Footnotes
F4
DCTH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+9,000
Change %
Price
$0.000000
Shares after
9,000
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,000
Exercise price
$10.16
Footnotes
F4
DCTH transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-9,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,000
Exercise price
$6.24
Footnotes
F5
DCTH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+9,000
Change %
Price
$0.000000
Shares after
9,000
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,000
Exercise price
$6.24
Footnotes
F5
DCTH transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-19,682
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,682
Exercise price
$7.25
Footnotes
F6
DCTH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+19,682
Change %
Price
$0.000000
Shares after
19,682
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,682
Exercise price
$7.25
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

This option was previously reported as covering 100,000 shares at an exercise price of $0.281 per share, but was adjusted to reflect the stock split that occurred on December 24, 2019.

Footnote F2

The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 1, 2019 and is fully vested.

Footnote F3

The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 23, 2020 and is fully vested.

Footnote F4

The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on August 5, 2021 and is fully vested.

Footnote F5

The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 4, 2022 and is fully vested.

Footnote F6

The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 12, 2023 and is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .